Medication info
Rabepica 10/700 mg (Rabeprazole Sodium, Sodium Bicarbonate)

Rabepica 10/700 mg (Rabeprazole Sodium, Sodium Bicarbonate)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tabletSodium Bicarbonate›700mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pale yellow oval film-coated tablet
Packaging
28 tablets/bottle
Approval status
Active

MFDS item code 202402102 · Approved 2024.08.30 · Insurance code 694004340

Summary

Main use
Treatment and maintenance of gastroesophageal reflux disease and relief of its symptoms; treatment of peptic ulcers (such as gastric ulcers)
Who takes it
Adults · Children
Adult dose
Although this medicine 10/700mg and 20/700mg contain 10 mg and 20 mg of rabeprazole sodium, respectively, note that the amount of sodium bicarbonate in two tablets of this medicine 10/700mg is not the same as that in one tablet of 20/700mg. 1) Gastric ulcer, duodenal ulcer: The usual adult dose is 10/700 mg orally once daily. Depending on symptoms, 20/700 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/700 mg or 20/700 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10/700 mg or 20/700 mg may be administered orally twice daily for an additional 8 weeks. However, the 20/700 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/700mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10/700mg once daily. 4) Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10/700mg or 20/700 mg orally once daily, depending on the patient. 2. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. 3. Patients with renal impairment: The safety and efficacy in patients with renal impairment have not been established. Use with caution because there is no experience with this medicine in these patients. 4. Elderly patients: Administer with caution because hepatic function is often reduced.
Child dose
5. Pediatric patients: Safety has not been established in pediatric patients.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment and maintenance of gastroesophageal reflux disease and relief of its symptoms; treatment of peptic ulcers (such as gastric ulcers)

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers. It is also effective for alleviating symptoms of erosive or ulcerative gastroesophageal reflux disease. Additionally, it is used in the long-term maintenance therapy of gastroesophageal reflux disease to help manage symptoms continuously. It is used to improve gastrointestinal diseases due to these effects.

How to take

Adult dose

Although this medicine 10/700mg and 20/700mg contain 10 mg and 20 mg of rabeprazole sodium, respectively, note that the amount of sodium bicarbonate in two tablets of this medicine 10/700mg is not the same as that in one tablet of 20/700mg. 1) Gastric ulcer, duodenal ulcer: The usual adult dose is 10/700 mg orally once daily. Depending on symptoms, 20/700 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. 2) Erosive or ulcerative gastroesophageal reflux disease: Administer 10/700 mg or 20/700 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10/700 mg or 20/700 mg may be administered orally twice daily for an additional 8 weeks. However, the 20/700 mg twice-daily regimen is limited to patients with confirmed severe mucosal damage. 3) Relief of symptoms of gastroesophageal reflux disease: Administer 10/700mg once daily. If symptoms are not controlled after 4 weeks of treatment, further medical evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10/700mg once daily. 4) Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10/700mg or 20/700 mg orally once daily, depending on the patient. 2. Patients with hepatic impairment: Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. 3. Patients with renal impairment: The safety and efficacy in patients with renal impairment have not been established. Use with caution because there is no experience with this medicine in these patients. 4. Elderly patients: Administer with caution because hepatic function is often reduced.

Child dose

5. Pediatric patients: Safety has not been established in pediatric patients.

Precautions

This medication should not be used in patients who have a history of allergy or hypersensitivity to its components. Women who are pregnant or breastfeeding should not take this medication. Caution should be exercised in patients with liver or kidney problems, elderly patients, and patients with compromised heart or lung function. This medication contains sodium and certain colorants, so patients who need to limit sodium intake or those with allergies to colorants should use it with caution. If any allergic symptoms such as rash or itching occur while taking this medication, discontinue use immediately and consult a doctor. It is important to undergo regular blood tests or liver function tests to check for abnormalities. Various side effects may occur in the heart, gastrointestinal tract, nervous system, skin, and respiratory system, so report any abnormal symptoms to medical staff immediately. There is a risk of osteoporosis or hypomagnesemia with long-term use, so regular testing is necessary. This medication suppresses gastric acid secretion and may affect the absorption or efficacy of certain medications, so it is critical to inform your doctor if you are taking other medicines. Be cautious as drowsiness or dizziness may occur when driving or operating machinery. There is no specific antidote for overdose, so symptomatic treatment is required, and it should be kept out of reach of children.

Side effects

Rash, hives, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechial hemorrhage, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, increased ALT, increased AST, increased ALP, increased γ-GTP, increased LDH, increased total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina pectoris, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QT prolongation, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distention, dyspepsia, belching, nausea, rectal bleeding, bloody stool, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenosis, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, hypervolemia, upper and lower extremity weakness, perceptual anesthesia, reduced grip strength, language confusion, unsteadiness, confusion, spatial disorientation, somnolence, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, pulmonary pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonicity, neuralgia, simple contraction, sweating, alopecia, skin dryness, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, polyuria, dysmenorrhea, urinary difficulty, nephrolithiasis, uterine bleeding, polyuria, gynecomastia, increased thyroid-stimulating hormone, bone fracture, gastric polyp, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, chest tightness, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure, alkalosis, edema due to sodium retention, gastric distention, rebound secretion of gastric acid

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent contact with air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Pale yellow oval film-coated tablet

Package unit

28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.